Bandou H - Search Results

1

Granulocyte Colony-Stimulating Factor Does Not Influence Clostridium Perfringens α-Toxin-Induced Myonecrosis in Mice.

Takehara M, Sonobe Y, Bandou H, Kobayashi K, Nagahama M. Takehara M, et al. Among authors: bandou h. Toxins (Basel). 2019 Aug 30;11(9):509. doi: 10.3390/toxins11090509. Toxins (Basel). 2019. PMID: 31480318 Free PMC article.

2

Clostridium perfringens α-toxin impairs granulocyte colony-stimulating factor receptor-mediated granulocyte production while triggering septic shock.

Takehara M, Seike S, Sonobe Y, Bandou H, Yokoyama S, Takagishi T, Miyamoto K, Kobayashi K, Nagahama M. Takehara M, et al. Among authors: bandou h. Commun Biol. 2019 Jan 31;2:45. doi: 10.1038/s42003-019-0280-2. eCollection 2019. Commun Biol. 2019. PMID: 30729183 Free PMC article.

3

Clostridium perfringens α-toxin specifically induces endothelial cell death by promoting ceramide-mediated apoptosis.

Takehara M, Bandou H, Kobayashi K, Nagahama M. Takehara M, et al. Among authors: bandou h. Anaerobe. 2020 Oct;65:102262. doi: 10.1016/j.anaerobe.2020.102262. Epub 2020 Aug 20. Anaerobe. 2020. PMID: 32828915

4

Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study.

Kato M, Baba H, Takekita Y, Naito M, Koshikawa Y, Bandou H, Kinoshita T. Kato M, et al. Among authors: bandou h. Eur J Clin Pharmacol. 2023 Nov;79(11):1515-1524. doi: 10.1007/s00228-023-03563-8. Epub 2023 Sep 13. Eur J Clin Pharmacol. 2023. PMID: 37700038 Clinical Trial.

5

Personality as a basis for antidepressant selection for patients with depression: A two-point outcome study at 4 and 8 weeks.

Naito M, Kato M, Koshikawa Y, Bandou H, Sakai S, Takekita Y, Nishida K, Kinoshita T. Naito M, et al. Among authors: bandou h. J Affect Disord. 2022 Oct 1;314:27-33. doi: 10.1016/j.jad.2022.07.001. Epub 2022 Jul 4. J Affect Disord. 2022. PMID: 35798178 Clinical Trial.

6

Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212).

Ohue M, Fujita S, Mizusawa J, Kanemitsu Y, Hamaguchi T, Tsukamoto S, Noura S, Yasui M, Itoh M, Shiomi A, Komori K, Watanabe J, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Moriya Y. Ohue M, et al. Among authors: bandou h. Jpn J Clin Oncol. 2022 Feb 5;52(2):114-121. doi: 10.1093/jjco/hyab183. Jpn J Clin Oncol. 2022. PMID: 34865105 Free PMC article. Clinical Trial.

7

[A Case of Rectal Cancer with Virchow Lymph Node Metastasis in Which Complete Response Was Achieved with Chemoradiation Therapy].

Sakimura Y, Yamamoto D, Saito H, Nishimura A, Sugita H, Hayashi K, Nishida Y, Tsuji T, Kitamura H, Kadoya S, Taima Y, Bandou H. Sakimura Y, et al. Among authors: bandou h. Gan To Kagaku Ryoho. 2020 May;47(5):843-846. Gan To Kagaku Ryoho. 2020. PMID: 32408333 Japanese.

8

Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).

Komori K, Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Shiomi A, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Kinugasa Y, Takii Y, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Komori K, et al. Among authors: bandou h. Eur J Surg Oncol. 2019 Mar;45(3):336-340. doi: 10.1016/j.ejso.2018.11.016. Epub 2018 Nov 20. Eur J Surg Oncol. 2019. PMID: 30477950 Clinical Trial.

9

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.

Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Murata K, Akagi Y, Takiguchi N, Saida Y, Nakamura K, Fukuda H, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Fujita S, et al. Among authors: bandou h. Ann Surg. 2017 Aug;266(2):201-207. doi: 10.1097/SLA.0000000000002212. Ann Surg. 2017. PMID: 28288057 Clinical Trial.

10

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

Kato M, Takekita Y, Koshikawa Y, Sakai S, Bandou H, Nishida K, Sunada N, Onohara A, Hatashita Y, Serretti A, Kinoshita T. Kato M, et al. Among authors: bandou h. J Psychiatr Res. 2017 Jun;89:97-104. doi: 10.1016/j.jpsychires.2017.02.003. Epub 2017 Feb 3. J Psychiatr Res. 2017. PMID: 28213170 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page